Home › NDC Lookup › RxCUI directory › RxCUI 1046266

Naphazoline hydrochloride 0.25 MG/ML / pheniramine maleate 3 MG/ML Ophthalmic Solution [Na... — RxCUI 1046266

RxNorm drug concept · Semantic branded drug
RxCUI 1046266 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1046266
Official nameNaphazoline hydrochloride 0.25 MG/ML / pheniramine maleate 3 MG/ML Ophthalmic Solution [Naphcon A]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asNaphcon A 0.025 % / 0.3 % Ophthalmic Solution; Naphcon A (naphazoline HCl 0.025 % / pheniramine maleate 0.3 % ) Ophthalmic Solution
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)2,382 prescriptions · 14 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Naphazoline / Pheniramine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It temporarily relieves two of the most annoying allergy eye symptoms: itching and redness. The drops work when your eyes are reacting to things like pollen, ragweed, grass, or pet...
  • What exactly does this product do for my eyes?
  • Adults and children 6 and older can use 1 or 2 drops in the affected eye(s) up to 4 times a day. It's important not to use them more often than that — overusing these drops can act...
  • No — you should take your contact lenses out before putting in the drops. The label is clear on this for all of these products. You can put your contacts back in after the drops ha...
📖 Read our full Naphazoline / Pheniramine guide →

🕸️ Concept Web — How Naphazoline hydrochloride 0.25 MG/ML / phenirami... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Naphazoline hydrochloride 0.25 MG/ML / pheniramine maleate 3 MG/ML Ophthalmic Solution [Naphcon A] RxCUI 1046266

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 5

    The active substance itself — no strength, form, or brand attached yet.

    • Naphazoline 7247
    • Pheniramine 8132
    • Naphazoline / pheniramine 597159
    • Naphazoline hydrochloride 82054
    • Pheniramine maleate 266959
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Naphcon A 218598
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Naphazoline / pheniramine Ophthalmic Solution 372997
    • Naphazoline hydrochloride / pheniramine maleate Ophthalmic Solution 2647788
    • Naphazoline / pheniramine Ophthalmic Product 1156987
    • Naphazoline hydrochloride / pheniramine maleate Ophthalmic Product 2660003
    • Naphazoline / pheniramine Ophthalmic Solution [Naphcon A] 93415
    • Naphazoline hydrochloride / pheniramine maleate Ophthalmic Solution [Naphcon A] 2657242
    • Naphcon A Ophthalmic Product 1178758
    • Ophthalmic Solution 7670
    • +1 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 18 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Naphazoline hydrochloride 0.25 MG/ML / pheniramine maleate 3 MG/ML Ophthalmic Solution SCD · 1043658
  • Naphazoline hydrochloride 0.25 MG/ML SCDC · 1043656
  • Pheniramine maleate 3 MG/ML SCDC · 1043657
  • Naphazoline / pheniramine Ophthalmic Solution SCDF · 372997
  • Naphazoline hydrochloride / pheniramine maleate Ophthalmic Solution SCDFP · 2647788
  • Naphazoline / pheniramine Ophthalmic Product SCDG · 1156987
  • Naphazoline hydrochloride / pheniramine maleate Ophthalmic Product SCDGP · 2660003

Brand-Name Concepts

  • Naphazoline hydrochloride 0.25 MG/ML / pheniramine maleate 3 MG/ML [Naphcon A] SBDC · 1046265
  • Naphazoline / pheniramine Ophthalmic Solution [Naphcon A] SBDF · 93415
  • Naphazoline hydrochloride / pheniramine maleate Ophthalmic Solution [Naphcon A] SBDFP · 2657242
  • Naphcon A Ophthalmic Product SBDG · 1178758
  • Naphcon A BN · 218598

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 1046266 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00065-0085-15 1 BOTTLE in 1 CARTON (0065-0085-15) / 15 mL in 1 BOTTLE Naphcon A Alcon Laboratories, Inc. 1995-01-03
50090-0185-00 1 BOTTLE in 1 CARTON (50090-0185-0) / 15 mL in 1 BOTTLE Naphcon A A-S Medication Solutions 2014-11-28
Observed labelers: A-S Medication Solutions (1) · Alcon Laboratories, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$0.5620
Range $0.5620–$0.5620 · middle 50% $0.5620–$0.5620 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.